THL – TorHoerman Law

Appellate Court Reverses Incretin Lawsuit Case Dismissals

 

(December 11, 2017) — The 9th Circuit U.S. Court of Appeals decided on Wednesday to reverse the dismissal of all incretin cases involved in incretin lawsuit MDL 2452, which had been previously dismissed by the Southern District of California tr Read More »

Invokana Risks Push Doctors to Switch Patients to Other Medications

 

The SGLT2 inhibitor Invokana has come under fire recently because of the increased risk of lower limb amputations caused by one of its key ingredients, canagliflozin. Physicians in California are hurrying to switch patients from Invokana to other dia Read More »

Judge Orders Science Day Hearings for Incretin Mimetics Lawsuits

 

On November 25, United States District Court Judge Anthony J. Battaglia issued an order calling for “Science Day” hearings, a special type of hearing typical in complex pharmaceutical drug litigation proceedings. These hearings, which wil Read More »

Diabetic Drugs, Januvia and Byetta Lawsuits Continue to Grow

 

In August 2013, the increasing number of lawsuits against drug manufacturers, Merck and Amylin led to the creation of a multidistrict litigation in the Southern District of California. Plaintiffs claim that diabetic drugs, Januvia and Byetta, cause s Read More »

Research Mounts Between Increased Risk of Pancreatic Cancer and the Type 2 Diabetes Drug Class Known as Incretin Mimetics

 

Scientific journals, studies and advocacy groups join the FDA in questioning the safety of the Type 2 diabetes drug class referred to as incretin mimetics, which includes brand name drugs such as Byetta, Bydureon, Victoza, Januvia and Janumet. Read More »

Pancreatic Cancer from Diabetes Drugs Litigation Moves Forward

 

As lawsuits move forward, individuals diagnosed with pancreatitis or pancreatic cancer after taking type 2 diabetes medications are advised to determine their legal rights – Read More »

Diabetes Drugs Pancreatic Cancer Litigation Proceeds – THL Attorneys Named as Leaders

 

Tor Hoerman and Jake Plattenberger named to leadership roles in diabetes drugs pancreatic cancer lawsuit consolidated in front Judge Anthony J. Battaglia in the Southern District of California. Read More »

Byetta, Januvia, Janumet and Victoza Cases Consolidated in Southern District of California

 

Litigation over diabetes drugs that manage blood insulin levels, referred to as Incretin Mimetics, continues to move forward. Plaintiffs and their families throughout the Country have alleged that they now suffer or have died from pancreatic cancer a Read More »

Federal Court Rules Amylin Can’t Avoid Byetta Pancreatic Cancer Cases in California State Court

 

 On July 10, 2013, a federal district court judge in San Diego rejected Amylin Pharmaceutical’s bid to avoid having to defend Byetta-induced pancreatic cancer cases in California state court.   Read More »

Filter News

No-Obligation Free Consultation

Contact us by phone at 1-888-508-6752 or email us below.

Sidebar Contact